logo
Under The Bonnet, Parkson Retail Asia's (SGX:O9E) Returns Look Impressive

Under The Bonnet, Parkson Retail Asia's (SGX:O9E) Returns Look Impressive

Yahoo02-04-2025

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an eye out for. In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earned from that capital are also increasing. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. Speaking of which, we noticed some great changes in Parkson Retail Asia's (SGX:O9E) returns on capital, so let's have a look.
The end of cancer? These 15 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. Analysts use this formula to calculate it for Parkson Retail Asia:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
0.28 = S$44m ÷ (S$324m - S$167m) (Based on the trailing twelve months to December 2024).
Thus, Parkson Retail Asia has an ROCE of 28%. In absolute terms that's a great return and it's even better than the Multiline Retail industry average of 7.0%.
See our latest analysis for Parkson Retail Asia
While the past is not representative of the future, it can be helpful to know how a company has performed historically, which is why we have this chart above. If you want to delve into the historical earnings , check out these free graphs detailing revenue and cash flow performance of Parkson Retail Asia.
We're delighted to see that Parkson Retail Asia is reaping rewards from its investments and has now broken into profitability. Historically the company was generating losses but as we can see from the latest figures referenced above, they're now earning 28% on their capital employed. At first glance, it seems the business is getting more proficient at generating returns, because over the same period, the amount of capital employed has reduced by 64%. The reduction could indicate that the company is selling some assets, and considering returns are up, they appear to be selling the right ones.
For the record though, there was a noticeable increase in the company's current liabilities over the period, so we would attribute some of the ROCE growth to that. The current liabilities has increased to 52% of total assets, so the business is now more funded by the likes of its suppliers or short-term creditors. Given it's pretty high ratio, we'd remind investors that having current liabilities at those levels can bring about some risks in certain businesses.
In the end, Parkson Retail Asia has proven it's capital allocation skills are good with those higher returns from less amount of capital. And a remarkable 1,280% total return over the last five years tells us that investors are expecting more good things to come in the future. Therefore, we think it would be worth your time to check if these trends are going to continue.
Parkson Retail Asia does have some risks though, and we've spotted 1 warning sign for Parkson Retail Asia that you might be interested in.
High returns are a key ingredient to strong performance, so check out our free list ofstocks earning high returns on equity with solid balance sheets.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Axsome's AXS-14 Gets Regulatory Setback with RTF, says Morgan Stanley
Axsome's AXS-14 Gets Regulatory Setback with RTF, says Morgan Stanley

Yahoo

time3 hours ago

  • Yahoo

Axsome's AXS-14 Gets Regulatory Setback with RTF, says Morgan Stanley

Axsome Therapeutics, Inc. (NASDAQ:AXSM) is one of the 13 Biotech Stocks with Huge Upside Potential. The FDA's Division of Anesthesiology, Addiction Medicine, and Pain Medicine has issued a Refusal to File letter for Axsome Therapeutics, Inc. (NASDAQ:AXSM) AXS-14 new drug application. A pharmacist preparing a prescription for a rapidly absorbed multi-mechanistic medicine. The submission was deemed incomplete by the agency due to the use of an 8-week primary endpoint in one of the two supporting trials and a flexible-dose schedule. Vikram Purohit, an analyst at Morgan Stanley, stated that Axsome Therapeutics, Inc. (NASDAQ:AXSM) intends to start a fresh 12-week primary endpoint trial with a fixed dose in Q4. The stock is still rated as overweight by Morgan Stanley, which has set a price target of $190. AXS-14's regulatory setback is viewed as a temporary setback. The regulatory development of AXS-05 for Alzheimer's disease agitation and the commercial success of Auvelity in major depressive disorder are seen by Morgan Stanley as Axsome Therapeutics, Inc. (NASDAQ:AXSM)'s primary 2025 value drivers. The company is nevertheless optimistic about Axsome Therapeutics, Inc. (NASDAQ:AXSM)'s overall pipeline momentum and prospects for near-term revenue growth despite the AXS-14 filing struggle. Axsome Therapeutics, Inc. (NASDAQ:AXSM) is a biopharmaceutical business in the clinical stage. It is involved in the development of new treatments for conditions of the central nervous system or CNS, for which there are few available options. The business is among the stocks with the biggest upside. While we acknowledge the potential of AXSM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None. Sign in to access your portfolio

Caring Together: Carefull to Partner with the Alzheimer's Association to Protect Families
Caring Together: Carefull to Partner with the Alzheimer's Association to Protect Families

Business Wire

time14 hours ago

  • Business Wire

Caring Together: Carefull to Partner with the Alzheimer's Association to Protect Families

NEW YORK--(BUSINESS WIRE)-- Carefull, the first financial safety platform built specifically for older adults and their families, is proud to support the Alzheimer's Association in raising awareness of the financial warning signs of cognitive decline and equipping families with tools to take early, protective action to prevent fraud and mistakes. Carefull is proud to support the care, services and research initiatives of the Alzheimer's Association. The Alzheimer's Association will provide information and resources aimed at helping families affected by dementia navigate financial challenges on Carefull's website. "Alzheimer's disease comes with a daily financial reality for families, and we are beyond proud to be working with the Alzheimer's Association to ensure financial safety is part of the cognitive health conversation" Share Designed to detect early behavioral signals and safeguard day-to-day finances, Carefull offers both a window into the early stages of cognitive change and a system to help preserve the financial independence and wellbeing of those affected. Carefull partners with financial institutions nationwide to bring these protections directly to the families they serve. Each year, more than 900,000 Americans develop Alzheimer's disease, with 7.2 million people aged 65 and older currently living with the condition. Behind each diagnosis is a network of loved ones offering critical support— nearly 12 million unpaid caregivers in the U.S. provide more than 19 billion hours of care annually for individuals with Alzheimer's or other dementias. 'We're committed to working with organizations that share our mission to protect and support older adults and their families. This effort is about helping families see what's happening sooner and act with confidence,' said Todd Rovak, Co-Founder of Carefull. 'Alzheimer's disease comes with a daily financial reality for families, and we are beyond proud to be working with the Alzheimer's Association to ensure financial safety is part of the cognitive health conversation.' Growing evidence shows that financial missteps—like missed bill payments, rising credit card debt, or unusual generosity—can signal early cognitive decline, including Alzheimer's. Research from institutions such as Johns Hopkins, Georgetown, and the National Institute on Aging suggests these behaviors may surface up to six years before a clinical diagnosis. Identifying these financial warning signs offers a powerful opportunity for early intervention and support. Carefull turns this insight into action, offering families and caregivers proactive tools that can detect behavioral changes in financial activity. Through real-time alerts, Carefull ScamCheck, trusted contact infrastructure, and an expert and empathetic care team, Carefull provides early signals that allow families to act before small issues become life-altering crises, and deploy a system to safeguard someone who may become vulnerable to inbound financial scams. Long before a diagnosis, subtle financial changes like missed bills, unusual spending, or increased vulnerability to scams, can be among the first signs that something is wrong. Early detection of Alzheimer's can make a significant difference in how families respond, plan, and care for a loved one. About Carefull Carefull is the first financial safety platform designed to protect aging adults and their families, from elder fraud, scams, and money mistakes. Built to support the unique needs of older adults, Carefull's proprietary AI provides 24/7 account monitoring, a suite of identity and home protections, along with expert resources to help families, advisors, and financial institutions safeguard families' financial well-being. Banks, credit unions, and wealth advisors use Carefull to deepen relationships across generations, provide proactive protection, and enhance trust with clients navigating both aging and financial caregiving for older adults. Recognized for its innovation in financial safety, Carefull partners with leading institutions to put financial care into financial services. Learn more at About the Alzheimer's Association The Alzheimer's Association is a worldwide voluntary health organization dedicated to Alzheimer's care, support and research. Our mission is to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia®. Visit or call 800.272.3900.

Discovering Fanli Digital TechnologyLtd And 2 Other Noteworthy Global Penny Stocks
Discovering Fanli Digital TechnologyLtd And 2 Other Noteworthy Global Penny Stocks

Yahoo

time17 hours ago

  • Yahoo

Discovering Fanli Digital TechnologyLtd And 2 Other Noteworthy Global Penny Stocks

As global markets continue to navigate a complex landscape, U.S. stocks have shown resilience with major indices climbing for the second consecutive week, driven by strong performances in small-cap and technology sectors. Amid these developments, investors might consider exploring opportunities beyond well-known giants, where penny stocks—often representing smaller or newer companies—can present intriguing possibilities. Although the term "penny stocks" may seem outdated, they remain a relevant area of investment that can offer surprising value when backed by solid financial health and potential for growth. Name Share Price Market Cap Financial Health Rating Lever Style (SEHK:1346) HK$1.15 HK$731.9M ★★★★★★ Foresight Group Holdings (LSE:FSG) £4.035 £453.9M ★★★★★★ Angler Gaming (NGM:ANGL) SEK3.66 SEK274.45M ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.43 SGD174.27M ★★★★★☆ Southern Cross Electrical Engineering (ASX:SXE) A$1.63 A$434.95M ★★★★★★ Tasmea (ASX:TEA) A$2.95 A$704.51M ★★★★★☆ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.31 SGD9.09B ★★★★★☆ DXN Holdings Bhd (KLSE:DXN) MYR0.505 MYR2.51B ★★★★★★ Bosideng International Holdings (SEHK:3998) HK$4.58 HK$52.24B ★★★★★★ Croma Security Solutions Group (AIM:CSSG) £0.86 £11.84M ★★★★★★ Click here to see the full list of 5,578 stocks from our Global Penny Stocks screener. Let's review some notable picks from our screened stocks. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Fanli Digital Technology Co., Ltd operates an e-commerce shopping guide platform in China, with a market cap of CN¥1.91 billion. Operations: The company's revenue is primarily derived from its Internet and related services segment, which generated CN¥233.11 million. Market Cap: CN¥1.91B Fanli Digital Technology Co., Ltd, with a market cap of CN¥1.91 billion, recently reported a decline in revenue to CN¥53.6 million for Q1 2025 from CN¥64.32 million the previous year, alongside an increased net loss of CN¥13.98 million. Despite its unprofitability and high share price volatility, the company remains debt-free and has not diluted shareholders over the past year. Its short-term assets significantly exceed both short-term and long-term liabilities, providing some financial stability amidst ongoing challenges in achieving profitability within the highly competitive e-commerce sector in China. Click to explore a detailed breakdown of our findings in Fanli Digital TechnologyLtd's financial health report. Examine Fanli Digital TechnologyLtd's past performance report to understand how it has performed in prior years. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Fangda Special Steel Technology Co., Ltd. operates in the steel industry, focusing on the production and sale of special steel products, with a market cap of CN¥9.55 billion. Operations: Fangda Special Steel Technology Co., Ltd. operates without reported revenue segments, focusing on the production and sale of special steel products. Market Cap: CN¥9.55B Fangda Special Steel Technology, with a market cap of CN¥9.55 billion, reported Q1 2025 earnings showing decreased revenue of CN¥4.35 billion from CN¥5.87 billion a year earlier, yet net income rose to CN¥250.34 million from CN¥93.41 million. The company's short-term assets exceed both its short-term and long-term liabilities, indicating financial stability despite negative operating cash flow and low return on equity at 4.1%. While the management team is relatively new with an average tenure of 0.6 years, the board is experienced with an average tenure of 6.1 years, suggesting strategic continuity amidst leadership changes. Click here to discover the nuances of Fangda Special Steel Technology with our detailed analytical financial health report. Explore Fangda Special Steel Technology's analyst forecasts in our growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Sanchuan Wisdom Technology Co., Ltd. manufactures and sells water meters under the San Chuan brand, with a market cap of CN¥4.40 billion. Operations: Sanchuan Wisdom Technology Co., Ltd. has not reported any specific revenue segments. Market Cap: CN¥4.4B Sanchuan Wisdom Technology, with a market cap of CN¥4.40 billion, has faced challenges as evidenced by decreased revenue and earnings over the past year. Despite reporting sales of CN¥213.34 million for Q1 2025, down from CN¥348.53 million a year ago, net income improved to CN¥16.31 million from a marginal profit previously. The company benefits from having more cash than total debt and its short-term assets significantly exceed both short-term and long-term liabilities, indicating strong liquidity management. However, declining profit margins and negative earnings growth remain concerns amidst an unstable dividend track record. Click here and access our complete financial health analysis report to understand the dynamics of Sanchuan Wisdom Technology. Assess Sanchuan Wisdom Technology's previous results with our detailed historical performance reports. Get an in-depth perspective on all 5,578 Global Penny Stocks by using our screener here. Contemplating Other Strategies? Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SHSE:600228 SHSE:600507 and SZSE:300066. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store